Guided Bone Regeneration Market
Guided Bone Regeneration Market - Global Assessment 2021 - 2031, Industry Analysis and Opportunity
Guided Bone Regeneration Market Segmented By Non-resorbable membranes and Reabsorbable Membranes having Indication such as Fenestration & Dehiscence, Socket Preservation, Pre-Implant Therapy, Sinus Lift Elevation prior to implant placement, Post Cystectomy
Guided Bone Regeneration Demand Outlook and CAGR:
According to the latest research by Persistence Market Research, Guided Bone Regeneration market is anticipated to grow at 6.3% CAGR during the forecast period. The Guided Bone Regeneration demand outlook is supposed to witness steady rise in the forecast period giving the manufacturers numerous beneficial opportunities of development in the near future.
Find Out More about the Report Coverage
What are the key drivers of the Guided Bone Regeneration Market?
The market for dental guided bone regeneration membranes will grow in response to the rising demand for dental implants and increasing incidence of oral health issues such as oral cancer and periodontal disease. In addition, manufacturers will increase market expansion in the anticipated time by expanding product development and focusing on meeting demand for effective therapies.
Increased awareness regarding implant procedures amongst the population of developing countries like India, Japan, Australia, and more is expected to drive the demand for guided bone regeneration market in the forecast period. India is one of the major market for dental implants.
Dental implants are gaining popularity in the U.S. because they are more functional than alternative treatment methods. Other factors like higher disposable incomes, combined with longer life expectancies, have increased the number of people seeking dental treatment. Furthermore, the introduction of new materials and technology, as well as the inclusion of dental implants in health insurance policies, are moving the guided bone regeneration industry forward.
According to a report published by the Center of Disease Control and Prevention, it was estimated that approximately 47.2% of the population above 30 years of age and 70.1% of the geriatric population in the U.S. suffers from some form of periodontal disease.
Periodontal disease is one of the major reason for surgeries involving guided bone regeneration. Thus, increased incidence of periodontal disease is expected to fuel the growth of guided bone regeneration market during the forecast period.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Additive Manufacturing: A paradigm shift in regenerative medicine technologies.
Additive manufacturing (AM) is a process where 3D structures are produced using automation by successive deposition of materials, layer-by-layer which is directed using Computer-Aided-Design (CAD) software.
The current clinical procedures that are aimed to reconstruct the hard or soft tissue defects which result from periodontal disease, congenital or acquired pathology or sometimes even trauma-related to the maxillofacial region, use mass-produced biomaterials for all the surgical indications. But, with the advent of AM, there is a paradigm shift in the manufacturing of these biomaterials with respect to individual patient needs.
The CAD systems use specific algorithms to design customized, image-based scaffolds with shape complexity and spatial patterning guided by topology optimization to create membranes for guided tissue regeneration specialized for every patient.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
U.S. and Canada Guided Bone Regeneration Demand Outlook
The U.S. and Canada region accounted for a significant share of the guided bone regeneration market on account of the usage of new and innovative products and technologies being used for treating various periodontal diseases. Along with the aforementioned factor, increased awareness and adoption of implant procedures amongst the population in this region is another reason why the industry will experience lucrative growth in the forecast period.
For instance, Orthocell, an Australia based regenerative medicine company received US 510k clearance in January 2021, to market and supply its collagen medical device StriateTM in the U.S. catering to the dental bone and tissue regeneration market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Europe Guided Bone Regeneration Demand Outlook
Europe region has the second-highest share of the guided bone regeneration industry after the U.S. and Canada region. This can be accounted for by the increased consumer awareness and knowledge about the benefits and perks of regenerative procedures to treat bone defects due to periodontal disease or other diseases affecting the oral cavity.
The reabsorbale membranes are more widely used in the European region. Increased disposable income, rising adoption of implant procedures by both physicians and patients, the inclusion of dental implants in the health insurances are some other reasons which will impact the guided bone regeneration market positively in the region during the forecast period.
For instance, Osstem Implant announced a product launch in April 2021, which was an addition to their guided bone regeneration portfolio called the ‘OssMem’, which is a bone regeneration membrane that would function both as a barrier and as a bioactive compartment. This product is aimed to ensure structural integrity essential for the regenerative function of the surgical site.
Who are the key manufacturers of Guided Bone Regeneration Industry?
The dominant players of Guided Bone Regeneration industry are
- Zimmer Biomet Holdings
- Danher Corporation
- Dentsply Sirona
- ACE Surgical
- Biotiss Biomaterials
- Keystone Dental
- Yantai Zhenghai Bio-tech Co. Ltd.
In September 2021, Geistlich Pharma became an exclusive distribution partner for NUsurface meniscus implant in Switzerland as a part of an exclusive partnership with Active Implants.
By Barrier Membrane Type:
- Non-resorbable membranes
- Expanded polytetrafluoroethylene (e-PTFE)
- High-density polytetrafluoroethylene (d-PTFE)
- Titanium mesh and titanium-reinforced PTFE.
- Reabsorbable Membranes
- Polyglycoside synthetic copolymers
- Calcium sulfate
- Fenestration & Dehiscence
- Socket Preservation
- Pre-Implant Therapy
- Sinus Lift Elevation prior to implant placement
- Post Cystectomy
- Dental Clinics
- Implant Centers
- Academic & Research Centers
- North America
- Latin America
- South Asia
- East Asia
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Guided Bone Regeneration Market Report Highlights:
- Shifting Industry dynamics.
- In-depth market segmentation.
- Historical, current and projected industry size recent industry trends.
- Key Competition landscape.
- Strategies for key players and product offerings.
- Potential and niche segments/regions exhibiting promising growth.
- A neutral perspective towards market performance.
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.